46th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190343836 | PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR | 2019-11-14 |
20190343837 | METHODS FOR TREATING CRYPTOSPORIDIOSIS USING TRIAZOLOPYRIDAZINES | 2019-11-14 |
20190343838 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | 2019-11-14 |
20190343839 | MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES | 2019-11-14 |
20190343840 | RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION | 2019-11-14 |
20190343841 | Medicinal Composition for Treating Intractable Heart Disease | 2019-11-14 |
20190343842 | USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS | 2019-11-14 |
20190343843 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | 2019-11-14 |
20190343844 | METHODS FOR THE TREATMENT OF BREAST CANCER | 2019-11-14 |
20190343845 | Natural combination hormone replacement formulations and therapies | 2019-11-14 |
20190343846 | PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY | 2019-11-14 |
20190343847 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | 2019-11-14 |
20190343848 | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS | 2019-11-14 |
20190343849 | ORAL DOSAGE FORM FOR ENHANCED SOLUBILIZATION OF A POORLY SOLUBLE ACTIVE AGENT AND METHOD OF PREPARATION | 2019-11-14 |
20190343850 | METHOD OF TREATING GLYCOGEN STORAGE DISEASE | 2019-11-14 |
20190343851 | METHODS FOR CANCER THERAPY | 2019-11-14 |
20190343852 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | 2019-11-14 |
20190343853 | METHODS OF TREATING HYPERTENSION | 2019-11-14 |
20190343854 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | 2019-11-14 |
20190343855 | PHARMACEUTICAL COMPOSITION FOR IMPROVING, PREVENTING OR TREATING MUSCLE RELATED DISEASE COMPRISING GINSENOSIDE RH2 | 2019-11-14 |
20190343856 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | 2019-11-14 |
20190343857 | PREBIOTIC COMPOSITION CONTAINING BUTYRYL-FRUCTOOLIGOSACCHARIDES | 2019-11-14 |
20190343858 | METHOD OF REGULATING THE CIRCADIAN RHYTHM OF AN INDIVIDUAL COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF A CIRCADIAN RHYTHM REGULATOR CONTAINING 1,2-DI-O-GALLOYL-4,6-O-(S)-HEXAHYDROXYDIPHENOYL-B-D-GLUCOSE | 2019-11-14 |
20190343859 | Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With Radiation | 2019-11-14 |
20190343860 | HIGHLY SELECTIVE ADENOSINE A3 RECEPTOR SUBTYPE AGONISTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS | 2019-11-14 |
20190343861 | METHOD OF USING PROTEIN KINASE A ACTIVATOR AND INHIBITOR IN PREPARATION OF DRUGS FOR TREATING DISEASES ASSOCIATED WITH CHANGES IN PLATELET COUNTS AND FOR INHIBITING AND PROMOTING PLATELET APOPTOSIS | 2019-11-14 |
20190343862 | DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS | 2019-11-14 |
20190343863 | MODULATION OF LNC05 EXPRESSION | 2019-11-14 |
20190343864 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS B | 2019-11-14 |
20190343865 | THERAPEUTIC TARGETS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | 2019-11-14 |
20190343866 | NUTRITIONAL COMPOSITION WITH RESISTANT STARCH USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES | 2019-11-14 |
20190343867 | BI SPECIFIC APTAMER | 2019-11-14 |
20190343868 | BENZIMIDAZOLES THAT ENHANCE THE ACTIVITY OF OLIGONUCLEOTIDES | 2019-11-14 |
20190343869 | NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | 2019-11-14 |
20190343870 | APPLICATION OF ALGINIC ACID SULFATE IN PREPARATION OF DRUGS AND HEALTH CARE PRODUCTS FOR PREVENTING AND TREATING DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES | 2019-11-14 |
20190343871 | Compositions and Methods for Inhibiting Shear Induced Platelet Accumulation | 2019-11-14 |
20190343872 | BULKING AGENTS | 2019-11-14 |
20190343873 | SEQUENCE-SELECTIVE GENE EXPRESSION REGULATORS | 2019-11-14 |
20190343874 | USE OF NICKEL COMPLEX IN PREPARING DRUG FOR RELIEVING INFLAMMATION | 2019-11-14 |
20190343875 | INTERNAL TEAT SEALANTS AND THEIR USE IN THE PREVENTION OF BOVINE MASTITIS IN THE DRY COW | 2019-11-14 |
20190343876 | TOPICAL COPPER ION TREATMENTS AND METHODS OF TREATMENT USING TOPICAL COPPER ION TREATMENTS IN THE DERMATOLOGICAL AREAS OF THE BODY | 2019-11-14 |
20190343877 | DECELLULARIZATION AND RECELLULARIZATION OF SOLID ORGANS | 2019-11-14 |
20190343878 | METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA | 2019-11-14 |
20190343879 | Methods and Systems for T Cell Expansion | 2019-11-14 |
20190343880 | CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT | 2019-11-14 |
20190343881 | THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS | 2019-11-14 |
20190343882 | Compositions and Methods for the Treatment of Demyelinating Conditions | 2019-11-14 |
20190343883 | RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2019-11-14 |
20190343884 | METHOD FOR PRODUCING FERMENTED MILK HAVING HIGH ANGIOTENSIN CONVERTING ENZYME INHIBITORY ACTIVITY AND METHOD FOR PRODUCING PHYSIOLOGICALLY ACTIVE PEPTIDE | 2019-11-14 |
20190343885 | COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY | 2019-11-14 |
20190343886 | COMBINATION INHIBITING MEIS PROTEINS | 2019-11-14 |
20190343887 | METHODS FOR INCREASING OSTEOBLASTIC FUNCTION | 2019-11-14 |
20190343888 | C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF | 2019-11-14 |
20190343889 | A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT | 2019-11-14 |
20190343890 | COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS | 2019-11-14 |
20190343891 | PLACENTAL TISSUE COMPOSITIONS | 2019-11-14 |
20190343892 | METHOD FOR PRODUCING AMNIOTIC MESENCHYMAL STROMAL CELL COMPOSITION, METHOD FOR CRYOPRESERVING THE SAME, AND THERAPEUTIC AGENT | 2019-11-14 |
20190343893 | Means and Methods to Treat Inflammation-Associated Disorders or Conditions | 2019-11-14 |
20190343894 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING SAME | 2019-11-14 |
20190343895 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 2019-11-14 |
20190343896 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 2019-11-14 |
20190343897 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | 2019-11-14 |
20190343898 | PROBIOTIC IMMUNOMODULATORY COMPOSITIONS | 2019-11-14 |
20190343899 | Oral Microbiota Transformation for the Relief of Immune System Associated Inflammations | 2019-11-14 |
20190343900 | Oral Microbiota Composition for Oral and/or Sinus Infections | 2019-11-14 |
20190343901 | Vehicles for Applying Bacteria to Skin, Scalp, and Hair | 2019-11-14 |
20190343902 | Treatment and Prophylaxis for Neurological Conditions and Diseases | 2019-11-14 |
20190343903 | ALTERED VIRUS | 2019-11-14 |
20190343904 | Oncolytic Poliovirus for Human Tumors | 2019-11-14 |
20190343905 | Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same | 2019-11-14 |
20190343906 | TABLET OF SPORODERM-REMOVED GANODERMA LUCIDUM SPORE AND PREPARATION METHOD THEREOF | 2019-11-14 |
20190343907 | Synergistic Compositions and Methods of Achieving Homeostasis in Mammalian Systems | 2019-11-14 |
20190343908 | Therapeutic Combination for the Treatment of Cancer | 2019-11-14 |
20190343909 | PROCESSED FOOD AND PHARMACEUTICAL COMPOSITION HAVING WATERMELON SPROUT-DERIVED SUBSTANCES AS MAIN INGREDIENTS | 2019-11-14 |
20190343910 | COMPOSITION AND METHOD FOR TREATING, PREVENTING, OR ALLEVIATING OSTEOPOROSIS | 2019-11-14 |
20190343911 | MASTIC-DERIVED NATURAL PROTECTANTS | 2019-11-14 |
20190343912 | METHODS AND COMPOSITIONS FOR MAINTAINING THE CONFORMATION AND STRUCTURAL INTEGRITY OF BIOMOLECULES | 2019-11-14 |
20190343913 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY | 2019-11-14 |
20190343914 | PEPTIDOMIMETIC MACROCYCLES | 2019-11-14 |
20190343915 | PEPTIDES FOR THERAPY | 2019-11-14 |
20190343916 | PEPTIDES USEABLE FOR TREATMENT OF DISORDERS OF THE EYE | 2019-11-14 |
20190343917 | SUSPENSIONS OF CYCLOSPORIN A FORM 2 | 2019-11-14 |
20190343918 | HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULATIONS | 2019-11-14 |
20190343919 | METHODS FOR TREATING PERIPHERAL NERVE INJURY | 2019-11-14 |
20190343920 | AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY | 2019-11-14 |
20190343921 | WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE | 2019-11-14 |
20190343922 | HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE | 2019-11-14 |
20190343923 | THERAPEUTIC AND COSMETIC USES AND APPLICATIONS OF CALRETICULIN | 2019-11-14 |
20190343924 | THERAPEUTIC AGENT FOR CARDIOMYOPATHY, OLD MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2019-11-14 |
20190343925 | SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN | 2019-11-14 |
20190343926 | Microburst Insulin Infusion Restores Carbohydrate Metabolism | 2019-11-14 |
20190343927 | EXPRESSION VECTOR FOR CHOLESTEROL 24-HYDROLASE IN THERAPY OF POLYGLUTAMINE REPEAT SPINOCEREBELLAR ATAXIAS | 2019-11-14 |
20190343928 | BACILLUS AMYLOLIQUEFACIENS GF423 STRAIN, AND COMPOSITION FOR PROVIDING ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITIES OR PREVENTING OR TREATING HYPERLIPIDEMIA, INCLUDING POLYPEPTIDE PRODUCED BY THE SAME | 2019-11-14 |
20190343929 | COMBINED THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY-SYNDROME) | 2019-11-14 |
20190343930 | METHOD FOR PREVENTING AND TREATING PATHOLOGICAL RENAL TISSUE INJURY | 2019-11-14 |
20190343931 | METHOD FOR MITIGATING HEART DISEASE | 2019-11-14 |
20190343932 | NOVEL TREATMENTS | 2019-11-14 |
20190343933 | RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE | 2019-11-14 |
20190343934 | VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE | 2019-11-14 |
20190343935 | METHODS AND COMPOSITIONS FOR TREATING TUMORS | 2019-11-14 |